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Summary
Bacteria surround their cytoplasmic membrane with 
an essential, stress-bearing peptidoglycan (PG) 
layer consisting of glycan chains linked by short 
peptides into a mesh-like structure. Growing and 
dividing cells expand their PG layer using inner-
membrane anchored PG synthases, including 
Penicillin-binding proteins (PBPs), which participate 
in dynamic protein complexes to facilitate cell wall 
growth. In Escherichia coli, and presumably other 
Gram-negative bacteria, growth of the mainly single 
layered PG is regulated by outer membrane-
anchored lipoproteins. The lipoprotein LpoB is 
required to activate PBP1B, which is a major, bi-func-
tional PG synthase with glycan chain polymerising 
(glycosyltransferase) and peptide cross-linking 
(transpeptidase) activities. In this work we show how 
the binding of LpoB to the regulatory UB2H domain 
of PBP1B activates both activities. Binding induces 
structural changes in the UB2H domain, which trans-
duce to the two catalytic domains by distinct allos-
teric pathways. We also show how an additional 
regulator protein, CpoB, is able to selectively modu-
late the TPase activation by LpoB without interfering 
with GTase activation.
Introduction
The morphology and physical robustness of almost all 
bacteria are maintained by peptidoglycan (PG), a major 
component of the cell envelope. In diderm Gram-negative 
bacteria such as the model Escherichia coli the peptido-
glycan forms a mainly single-layered, mesh-like sacculus 
situated within the periplasm (Gan et al., 2008; Vollmer et 
al., 2008). The PG sacculus encases the cell’s cytoplas-
mic membrane and is essential for cell survival. Several 
classes of antibiotics, such as β-lactams and glycopep-
tides, exploit this essentiality by targeting the PG synthesis 
pathways causing cell death (Schneider and Sahl, 2010). 
The sacculus is itself surrounded by the outer membrane 
(OM), an asymmetric layer of phospholipids and lipopoly-
saccharide which provides a crucial permeability barrier 
for the cell, preventing harmful compounds from gaining 
access beyond (Nikaido, 2003; Tokuda, 2009; May and 
Silhavy, 2016). Several abundant proteins anchored in 
the OM bind to the PG layer, and this tight connection is 
important for maintaining cell envelope stability (Hantke 
and Braun, 1973; Godlewska et al., 2009; Egan, 2018). 
Together the layers of the cell envelope work to protect 
the cell from both mechanical and chemical insults.
The PG sacculus consists of a repeating disaccharide 
unit, N-acetylglucosamine (GlcNAc) and N-acetylmuramic 
acid (MurNAc), polymerised into glycan chains which are 
connected to each other by short peptides stemming 
from MurNAc (Vollmer et al., 2008). This basic structure 
is repeated across the entire sacculus creating a mesh 
made up of a single, continuous macromolecule. In order 
to grow and divide, bacteria must carefully enlarge this 
molecule in coordination with the growth of the other key 
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envelope components of the cell (Typas et al., 2012; Egan 
et al., 2016). Any failure in the synthesis and incorpora-
tion of new PG could compromise structural integrity and 
lead to cell death. As such E. coli maintains a repertoire 
of regulatory elements for the control of its PG synthase 
enzymes (Typas et al., 2012; Egan et al., 2015; 2016), 
however, the molecular mechanisms of this regulation are 
largely unexplored.
Two synthetic activities are required for the insertion of 
new material into the sacculus during growth and division. 
Glycosyltransferase (GTase) activity polymerises the 
precursor lipid II into glycan chains and transpeptidase 
(TPase) activity links the stem peptides of these chains 
together and/or to the existing sacculus, thereby incor-
porating new material allowing for growth (Egan et al., 
2016). The major synthases in E. coli, responsible for the 
majority of PG growth, are two class A penicillin-binding 
proteins (PBPs), PBP1A and PBP1B. The cell requires 
at least one of these enzymes for growth (Yousif et al., 
1985; Denome et al., 1999). Class A PBPs possess both 
catalytic activities required for the enlargement of the PG 
sacculus by virtue of two structurally distinct, but func-
tionally coupled, GTase and TPase domains. Function of 
the TPase domain requires ongoing activity of the GTase 
(Born et al., 2006). These enzymes also show minor 
carboxypeptidase activity through side-reactions of their 
TPase function (Egan et al., 2015). E. coli also has two 
monofunctional TPase enzymes, PBP2 and PBP3, which 
are essential for elongation of the cylindrical rod-shaped 
cell during growth, and for cell division, respectively 
(Bertsche et al., 2006; Banzhaf et al., 2012; Egan et al., 
2015). PBP1A interacts with PBP2, working during elon-
gation orchestrated by the cytoplasmic, actin-like, MreB 
(Banzhaf et al., 2012). PBP1B interacts with PBP3, work-
ing during cell division as part of the divisome complex 
ultimately controlled by the cytoplasmic tubulin-homo-
logue FtsZ (Bertsche et al., 2006; Müller et al., 2007; Du 
and Lutkenhaus, 2017; Leclerq et al., 2017). PBP1A and 
PBP1B both also interact with OM-anchored lipoproteins 
LpoA and LpoB, respectively (Paradis-Bleau et al., 2010; 
Typas et al., 2010). In both cases, the interaction of each 
Lpo with its cognate synthase is absolutely essential for its 
function in the cell, activating the enzymes’ TPase activity 
(Typas et al., 2010; Lupoli et al., 2014). This revealed a 
new paradigm in Gram-negative PG growth regulation, as 
the synthases are not only regulated from inside the cell 
by cytoskeletal elements, but also from outside the sac-
culus, suggesting that the cell adjusts the PG synthesis 
rate in response to the local pore size in the mesh-like 
sacculus (Typas et al., 2010; 2012).
In addition to the two catalytic domains, the PBP1B 
crystal structure revealed the presence of a small, 
non-catalytic domain called UB2H (Sung et al., 2009; King 
et al., 2016). Analysis of the protein sequence of PBP1A 
also revealed a similar non-catalytic domain called ODD 
(Typas et al., 2010). In fact, numerous class A PBPs 
across the bacterial kingdom possess such non-cata-
lytic domains (Typas et al., 2012). It was recently shown 
that P. aeruginosa PBP1B, which has a UB2H domain 
but no LpoB homologue according to sequence data, has 
its own unique Lpo protein ‘LpoP’ (Greene et al., 2018). 
As with the E. coli Lpo proteins LpoP is essential for 
Pseudomonas PBP1B function. In order to interact with 
and regulate PBP1B in E. coli, LpoB’s structured domain 
reaches from its anchor point in the OM by virtue of a 
145 Å long disordered sequence to interact directly with 
UB2H via a relatively large interface (Egan et al., 2014). 
This interaction stimulated both the GTase and TPase 
activities of PBP1B. The question nevertheless remained, 
how does interaction with the non-catalytic UB2H domain 
activate both catalytic domains of PBP1B? Interestingly, a 
genetic screen isolated three PBP1B versions with amino 
acid substitutions clustering in the inter-domain region of 
the synthase, and one in the GTase domain, which par-
tially bypass the need for activation by LpoB (Markovski 
et al., 2016). This supports a model in which activation of 
the synthase proceeds via a conformational change ini-
tiated by LpoB binding to its UB2H domain (Egan et al., 
2014; Markovski et al., 2016). This hypothesis was further 
supported by the isolation of P. aeruginosa PBP1B ver-
sions with similar Lpo bypass mutations (Greene et al., 
2018). However, the mechanism by which LpoB binding 
activates both PG synthesis activities simultaneously 
remained elusive.
An additional layer to the regulation of PBP1B by LpoB 
was subsequently discovered in E. coli. The Tol-Pal asso-
ciated protein CpoB interacts with PBP1B and selectively 
inhibits the LpoB-mediated activation of TPase, but not 
GTase, activity in response to Tol-Pal function in the cell 
(Gray et al., 2015). Tol-Pal is implicated in many roles 
related to OM integrity across several Gram-negative 
species, including in OM constriction during cell division 
(Gerding et al., 2007; Egan, 2018). This selective uncou-
pling of the two activation effects suggests that CpoB 
binding blocks only the conformational change affecting 
the TPase domain and not GTase but this remained to be 
investigated.
Here, we present the structure of the isolated UB2H 
domain in solution and confirm the stability of its fold in 
the absence of the TPase and GTase domains. We show 
that the binding of LpoB to UB2H induces limited con-
formational and dynamic changes in the domain, mainly 
localised at the extremities that are normally linked to the 
rest of the PBP1B structure both covalently and through 
hydrogen-bonding networks. Based on this evidence, we 
investigated the importance of these hydrogen-bonding 
networks which connect UB2H with the TPase and GTase 
domains, by testing the cellular functionality of PBP1B 
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versions altered in key residues. We then tested the activ-
ity of these versions, and their interaction with and acti-
vation by LpoB. Our findings show that binding of LpoB 
to UB2H induces two distinct yet overlapping allosteric 
activation routes through the domain, impacting the activ-
ities of the GTase and TPase domains through localised 
hydrogen-bonding reorientation. This reorganisation could 
structurally explain the activation process of the two cata-
lytic domains and also reveals the importance of structural 
dynamics in class A PBP activity. Furthermore, we deter-
mine the structure of the C-terminal TetratricoPeptide 
Repeat (TPR) domain of E. coli CpoB, identify the inter-
action surfaces between this domain and PBP1B, and 
infer a mechanism by which binding achieves selective 
inhibition of TPase activation.
Results
Binding of LpoB alters the structure of UB2H
To investigate possible structural changes to the UB2H 
domain resulting from LpoB binding we expressed and 
purified the UB2H domain of E. coli PBP1B (residues 
108 to 200) and determined its structure by NMR spec-
troscopy. All NMR data recorded pointed towards the 
presence of a stable fold for the isolated UB2H domain 
in solution and were used to calculate a high-resolution 
structure (see Table S1). Superimposition of the 20 low-
est energy structures derived from NMR (PDB 6FZK) with 
the UB2H domain from the X-ray crystal structure of full-
length PBP1B (PDB 5FGZ) shows a similar secondary 
structure organisation with a backbone rmsd of 1.1 Å for 
residues involved in secondary structures (Fig. 1A). As 
described for the X-ray structure (Sung et al., 2009; King 
et al., 2016), the domain architecture is formed by one 
α-helix followed by four long β-strands (β2 to β5), which 
are linked by mostly short turns to form an anti-parallel 
β-sheet. Only the turn between stands β3 and β4 forms 
a larger loop (Loop 1: residues 157 to 168). This loop 
shows a lower resolution in our NMR structure, which is 
correlated to an increase in flexibility in solution in this 
region, as evidenced by 15N-NMR relaxation measure-
ments (R2/R1 and 1H-15N heteronuclear NOE are shown 
in Fig. S1A). The N- and C-terminal extremities of the 
UB2H domain interact through two extended anti-paral-
lel β segments (residues 109–115 and 193–200) that are 
Fig. 1. Binding of LpoB induces structural changes in UB2H. 
Superimposition of the 20 lowest energy structures derived from NMR of (A) the isolated UB2H domain (in pale blue, PDB 6FZK) or (B) the 
UB2H domain in complex with LpoB (in blue, PDB 6G5R) and of the X-ray structure of the UB2H domain in full-length PBP1B (PDB code 
5FGZ, in purple). Residues that showed a significant chemical shift perturbation upon binding of LpoB are shown in red in panel B. 
C. The same residues are coloured in red on the previously reported model that was obtained from a data-driven docking of the PBP1B 
X-ray structure (PDB 3FWL) and the NMR LpoB structure (PDB 2MII). This model was calculated based on the LpoB CSP induced by UB2H 
binding and on the identification of few UB2H residues that impacted activation of PBP1B upon in vivo mutations (Egan et al., 2014). Labels 
and sticks for side chains are displayed for the concerned mutated residues. For clarity, the zoom presented in the right panel corresponds to 
a partial view selected to emphasise the N- and C-terminal extremities of UB2H as well as the loop region 186 to 191 that is important for the 
interaction with LpoB. The two UB2H extremities (residues 109–115 and 193–200) are covalently linked to β-strands β1 and β7 that form the 
inter-domain region of PBP1B. 
D. Protein sequence of the UB2H domain with residues in red that showed a significant perturbation upon LpoB binding and identification of 
secondary structure elements in free UB2H. [Colour figure can be viewed at wileyonlinelibrary.com]
A C
B
D
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connected to two very short β-strands, β1 (105–108) and 
β7 (202–204), that form the intermediate region connect-
ing the TP and GT domains in full-length PBP1B (PDB 
5FGZ).
To monitor possible modifications induced by the 
binding of LpoB, [13C,15N]-labelled UB2H was prepared 
and mixed with an unlabelled LpoB sample (Fig. S1A). 
The structure of UB2H in complex with LpoB was cal-
culated using the same procedure as used for UB2H 
alone and deposited in the PDB (PDB 6G5R). Fig. 1B 
shows the 20 lowest energy structures calculated for 
UB2H in complex with LpoB. With the exception of the 
small anti-parallel β-sheet formed between the N- and 
C-terminal extremities (residues 109–115 and 193–200) 
of UB2H, all of the secondary structures initially pres-
ent in UB2H alone were conserved in the complex (Fig. 
S1B) and the set of UB2H structures in the complex with 
LpoB could be superimposed with a backbone rmsd of 
1.2 Å (calculated for residues in secondary structures) 
to the X-ray structure of the UB2H domain of PBP1B 
(PDB 5FGZ).
To determine the relative position of LpoB in complex 
with UB2H, we searched for intermolecular distances 
between the two domains in 3D edited-NOESY and in 
2D 13C,15N-filtered NOESY. No intermolecular distance 
was detectable, consistent with the fast dynamics of the 
complex formation as revealed by chemical shift pertur-
bations measured on LpoB or UB2H (Fig. S1C) and with 
surface plasmon resonance (SPR) measurements (Egan 
et al., 2014). To map the interface between both proteins, 
we measured the NMR chemical shift perturbations 
(CSP) induced on the amide groups of UB2H (Fig. S1C). 
Residues that showed CSP larger than two standard devi-
ations on the UB2H domain or that corresponded to com-
pletely disappearing resonances are coloured in red in 
Fig. 1C. The majority of the large CSP observed localise 
close to the surface of interaction with LpoB in agreement 
with our previous model (Egan et al., 2014). This initial 
model was calculated based on NMR data measured 
exclusively on LpoB and validated with six key UB2H 
mutations that impacted the LpoB interaction. While the 
majority of the CSP in UB2H can be explained by a direct 
proximity with LpoB, other distal changes could result 
from structural rearrangements upon binding of LpoB. 
These structural modifications were confirmed by the dif-
ference in Chemical Shift Index (CSI) between the free 
and bound form of UB2H as determined from HN, N, C, 
C and CO resonances (Berjanskii and Wishart, 2005) 
(Fig. S1B). The destabilisation of the N- and C-terminal 
β-sheet induced by LpoB would modify the network of 
contacts between UB2H and the rest of PBP1B and likely 
underlies pathways to transfer the activation signal to the 
catalytic sites.
Structural changes in UB2H activate PBP1B
Based on these structural data, we identified two candi-
date pathways of conformational change through UB2H, 
one connected to the GTase domain via residues proxi-
mal to loop 1, and the other one connected to the TPase 
domain via the termini of UB2H (Fig. 1C and Table 1). We 
predicted that the substitution of charged polar residues 
R196 and D198 impacts the dynamics of Loop 1 and the 
positioning of R157 within it. R157 forms a H-bond with 
E341, a residue proximal to the cap of α-helix 7 in the 
GTase domain, and so reorientation of Loop 1 may in 
turn impact the orientation and/or movement of this helix 
(Fig. 2A). Helix 7 ends with K355 in the GTase domain 
active site cleft, and is proximal to Q318 in the glycan 
chain exit channel. Additionally we predicted that the 
local flexibility induced at the termini of UB2H by dis-
ruption of the β1′/β7′ β-sheet may impact the orientation 
and/or movement of α-helix 14 in the TPase domain, the 
capping residue of which (D443) forms a H-bond with 
R109 in this region. Additionally, we investigated how 
the PBP1B mutant allele I202F derived from the genetic 
screen of Markovski et al. (2016) may achieve its LpoB 
bypass effect and found that this substitution may reori-
ent local stacking of aromatic residues impacting the 
inter-domain region of PBP1B proximal to both Loop 1 
and the base of α-helix 14, including residue K437. We 
constructed 17 PBP1B mutant alleles carrying substitu-
tions in amino acids predicted to be part of each pathway 
or in the inter-domain region, our reasoning for each sub-
stitution is summarised in Table 1.
Blocking or mimicking the putative activation pathways. For 
the putative pathway to the GTase domain we sought to 
block the H-bonding network by substitution of D198, 
R157 and E341 to Ala, and potential downstream effects 
of the reorientation of α-helix 7 in the GTase domain by 
substituting K355 and Q318 to Ala. We substituted R196 
in strand β7′ for Gly in an attempt to induce local flexibility 
and possibly mimic the activation signal. Additionally we 
substituted R134, a residue which also H-bonds with 
E341, to Glu to assess the effect of a charge reversal 
on activity. For the putative pathway through the UB2H 
termini we sought to mimic the signal by substitution 
of R109 and N112 to Gly, attempting to destabilise the 
β-sheet artificially inducing local flexibility, and to abolish 
H-bonding of α-helix 14 with this region by substituting 
D443 with Ala (Fig. 2A). R196G may also impact this 
pathway as it is situated proximal to this β-sheet.
Seventeen PBP1B versions carrying substitutions were 
assessed for in vivo function by two genetic experiments. 
Throughout this work, the expression plasmids carry-
ing mrcB alleles were sequenced to confirm the correct 
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mutation. Strains lacking the native mrcB gene (encoding 
PBP1B) and expressing different PBP1B versions from 
an expression plasmid had their fitness measured in the 
presence of cefsulodin at concentrations below the MIC. 
Cefsulodin is a β-lactam specific for PBP1A and PBP1B, 
but which targets mainly PBP1A function leaving the cells 
dependent on PBP1B for growth (Yousif et al., 1985; 
Denome et al., 1999; Curtis et al., 1979). The expres-
sion of each version was confirmed by western blot (Fig. 
S2A). The second experiment tested whether these same 
strains could survive after deletion of the gene encoding 
PBP1A (mrcA) (Fig. 2B). The two approaches gave con-
sistent results (Fig. 2B).
Disruption of the GTase activation pathway resulted 
in a loss of PBP1B in vivo function, with substitution of 
R157 and E341 particularly detrimental to fitness. R196G 
and R134E had a minor effect on fitness, and gave ~ half 
the number of colonies post mrcA deletion relative to 
WT. Attempted mimicry of the TPase activation pathway 
yielded versions whose in vivo fitness was equivalent to 
WT with the exception of R109G, which had a dominant 
negative impact. Whenever R109G was present PBP1B 
was rendered non-functional regardless of additional sub-
stitutions (Fig. 2B). Substitution of K437 to Ala impeded 
fitness, and survival of cells after deletion of mrcA was 
poor compared to WT. Cells expressing PBP1B with the 
I202F substitution were fitter than those expressing WT 
PBP1B at concentrations of cefsulodin below the MIC.
Next, we purified 16 different PBP1B substitution ver-
sions for in vitro assay of the effect these changes had 
on GTase and TPase activity. All purified PBP1B versions 
were stable at 37°C for at least 1 h and bound the fluores-
cent β-lactam Bocillin, indicating that their TPase domain 
was properly folded (Fig. S2B). We used two assays to 
measure basal activity and the stimulatory effect of LpoB 
on each version compared to WT. We used an end-point 
PG synthesis assay with [14C]-labelled lipid II substrate 
to quantify peptide cross-linking and carboxypeptidase 
products as a percentage of the total PG product (we 
summarise these products of the TPase domain as ‘Total 
TPase products’). For reference throughout this section, 
WT PBP1B produced a PG with 49.9 ± 2% TPase prod-
ucts (Fig. 3A) which we refer to as its basal TPase activity. 
We also used a continuous fluorescence assay with dan-
sylated lipid II, which cannot be used as TPase substrate, 
to measure GTase rate. In all results, these data are pre-
sented as the rate relative to WT PBP1B’s basal GTase 
activity, unless specified otherwise (Fig. 3B). From these 
data several classes of substitution were apparent: those 
that impact both activities positively, those impacting both 
negatively, and those that impact one or the other either 
positively or negatively. The impact of each substitution(s) 
on both basal activity and LpoB activation of the GTase 
and TPase domains relative to each other are shown in 
Fig. 3C and D. The in vitro activities observed are consis-
tent with in vivo functionality (Fig. 2B).
Table 1. PBP1B activation signal perturbation versions.
PBP1B version Domain/position Substitution rationale
R196G UB2H/termini β-sheet Chemical shift perturbation (CSP) observed in presence of LpoB. Directly upstream of LpoB 
interacting residues E187, N188, R190 and Q191. Substitution with Gly expected to induce 
local structural flexibility.
D198A UB2H CSP observed in presence of LpoB, H-bond with R157. Substitution with Ala will abolish 
H-bond.
R134E UB2H H-bonds with E341 and R157. Charge-flip substitution expected to disrupt H-bond and alter 
local structure/dynamics.
R157A UB2H/loop 1 Connected to destabilised β-sheet through H-bonding with D198. H-bond with E341. 
Substitution to Ala will disrupt this H-bond.
E341A GTase Connection point between UB2H and GTase via H-bond with R157. Proximal to cap of 
α-helix 7. Substitution with Ala will disrupt the H-bond to R157 and R134.
K355A GTase/active site cleft Residue at opposite end of α-helix 7 to E341, proximal to essential catalytic E233 residue in 
active site cleft. We expected substitution of this charged residue with Ala to affect local 
structure/dynamics in the GTase catalytic site.
Q318A GTase/glycan exit 
channel
Proposed to form the base of the GT donor binding cleft. Substitution to Ala to remove large 
polar side chain.
K437A Inter-domain region Proximity with the extremity of UB2H Loop 1. We expected substitution of this charged 
residue with Ala may disrupt local structure dynamics.
I202F Inter-domain region Version found by Markovski et al. which increases PBP1B activity and partially bypasses 
reliance on LpoB.
R109G UB2H CSP observed in presence of LpoB. H-bond with D443. Substitution with Gly expected to 
induce local structural flexibility and abolish its H-bond with D443.
N112G UB2H/termini β-sheet CSP observed in presence of LpoB. Part of β1′-strand. Substitution with Gly expected to 
induce local structural flexibility and disrupt the β1′-strand.
D443A TPase/α14 Caps α-helix 14 in the TPase domain, H-bond with R109 in UB2H. We expected substitution 
to disrupt the H-bond with R109 and affect structural dynamics of α-helix 14.
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Substitutions negatively affecting both GTase and TPase 
activities. As the GTase and TPase activities of class 
A PBPs are coupled (Bertsche et al., 2005; Born et al., 
2006; Lupoli et al., 2014) we expected that some of the 
targeted substitutions we made (Table 1) to affect both of 
the two putative activation pathways. Consistent with its 
dominant negative effect on in vivo function, the presence 
of the R109G substitution decreased the basal GTase and 
TPase activities of PBP1B. TPase products were reduced 
to 42.3 ± 1.3%, and the GTase rate of PBP1B R109G was 
~ half (0.55-fold) of WT (Fig. 3A–C). Furthermore, while 
the R109G substitution did not prevent activation of the 
synthase by LpoB (Fig. 3D), the overall GTase and TPase 
activities did not reach WT levels.
A similar activity profile was observed for R157A and 
E341A, decreasing TPase products to 39.0 ± 3.4% and 
Fig. 2. Perturbation of the putative activation pathways. 
A. H-bond network connecting points of structural change in UB2H domain with the other domains of PBP1B (green dashed lines between 
residues) (PDB code 5FGZ). This network involves residues (coloured in red) mainly located in the N- and C-terminal segments and in Loop 
1 (residues 109–114, 196–200 and 157–168, respectively) ultimately connecting the UB2H domain with residue D443 of the TPase domain, 
and residue E341 of the GTase domain. Residues coloured in blue represent the mutations of PBP1B that partially bypass the need of LpoB 
activation (Markovski et al., 2016). 
B. In vivo function of PBP1B versions as measured by cellular fitness under cefsulodin treatment (6 μg/mL). Cefsulodin primarily targets 
PBP1A, increasing the cell’s dependence on PBP1B. Colony size relative to the strain expressing WT PBP1B is used as proxy of cellular 
fitness; growth of the strain harbouring the empty vector represents basal growth (mean ± SD; n = 16). Each bar is coloured according to 
survival of the strain harbouring the specific PBP1B version once mrcA (encoding PBP1A) was deleted in three independent experiments. 
Blue, growth similar to WT; light blue, diminished growth compared to WT (≤ 50%); red, no growth. Expression of PBP1B versions from their 
pET28 vector in BW25113 ΔmrcB was not induced, relying on basal expression from a cryptic promoter (Egan et al., 2014). [Colour figure can 
be viewed at wileyonlinelibrary.com]
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41.5 ± 2.4%, respectively (Fig. 3A) and GTase rate to 
~0.6 and 0.7-fold of WT, respectively (Fig. 3B). As pre-
dicted, these substitutions also strongly impact on GTase 
activation by LpoB (Fig. 3B and D).
Substitutions positively affecting both activities. Another 
class of substitutions which affect both activities, in this 
case positively, include R134E, N112G and D443A. 
R134E, which was predicted to impact the GTase 
activation pathway (Fig. 2A), caused a minor increase 
in basal GTase (up ~1.3-fold, Fig. 3B) and TPase 
(54.1 ± 1.8%, Fig. 3A) activities. Activation by LpoB 
increased the total activity to the same level as WT 
PBP1B suggesting the positive effect of the substitution 
could not be further enhanced (Fig. 3A–D). N112G and 
D443A substitutions were predicted to mimic the effect 
of LpoB binding on TPase activity. While these single 
substitutions were insufficient to fully mimic the activation 
signal both caused a significant increase in TPase activity 
compared to WT alone at 53.9 ± 2.3% with N112G and 
57.8 ± 1% with D443A (Fig. 3A). N112G also caused a 
concomitant minor increase in basal GTase activity (up 
~1.6-fold, Fig. 3B) with no impact on overall activity in 
the presence of LpoB. D443A caused a more substantial 
increase in both basal GTase (up ~2.5-fold) and in the 
activation by LpoB, giving a total rate at 15.6-fold greater 
than WT PBP1B (Fig. 3B and C). Furthermore, D443A 
allowed the synthase to produce more TPase products in 
the presence of LpoB, up from 71.0 ± 1.8% to 75.3 ± 2.9% 
(Fig. 3A). Both the GTase and TPase data suggest that 
the D443A substitution enhances the stimulatory effect 
of LpoB, enabling even greater levels of activity than the 
WT, unlike for R134E and N112G alone.
I202F, a substitution allele of PBP1B selected as a sup-
pressor of cefsulodin hypersensitivity in a ΔlpoB strain 
that can partially bypass the requirement for LpoB bind-
ing indeed had significantly increased basal activities. 
TPase products increased to 64.1 ± 1.3% (Fig. 3A) and 
GTase rate 7.9 ± 1.9-fold compared to WT PBP1B (Fig. 
3B). However neither was increased to the same level as 
WT PBP1B-LpoB (at 71.0 ± 1.8% and 10.2 ± 0.9-fold, 
respectively). In fact both activities were still increased 
by LpoB binding to levels equivalent to total WT PBP1B-
LpoB (Fig. 3A and B) suggesting that the I202F substitu-
tion indeed mimics the majority of the activation signal(s), 
and that LpoB binding cannot cause much further stimu-
latory change in this version, contrary to version D443A 
discussed above.
Combined Gly substitutions boost TPase activation by 
LpoB. Substitution of R196 to Gly, which we predicted 
may mimic GTase activation, had no effect on activity 
(Fig. 3A–D). While the R109G substitution had a negative 
impact on basal PBP1B activity and total activity in the 
presence of LpoB (Fig. 3A and B), stimulation by LpoB 
increased synthesis of TPase products similarly to the 
increase observed in WT PBP1B (Fig. 3D). However, 
when the R109G substitution is combined with the 
N112G and/or R196G substitutions the activation of the 
TPase activity of these versions by LpoB was increased 
compared to WT PBP1B (Fig. 3D). LpoB increased WT 
TPase activity by 21.1 ± 2.8%, while PBP1B versions 
R109G/N112G, R109G/R196G and R109G/N112G/
R196G are activated by 25.8 ± 1.9%, 24.8 ± 1.0% and 
26.3 ± 1.0%, respectively (Fig. 3D). This suggests that 
the presence of the multiple structure-breaking Gly 
Fig. 3. Perturbation of activation pathways impacts regulation of PBP1B. 
A. Total TPase activity of each PBP1B version. Data are the total products resulting from TPase domain activity (both peptide cross-linking 
and minor carboxypeptidase) during in vitro PG synthesis using native [14C]-lipid II substrate (mean ± SD, n = 3–4). The presence or absence 
of LpoB is indicated beneath appropriate bars with a + or −, respectively. Statistical significance was tested by paired T-Test compared to the 
appropriate WT activity (basal version activity to basal WT, activation by LpoB to WT PBP1B + LpoB); N.S., not significantly different;  
*
, P ≤ 0.05; **, P ≤ 0.005. 
B. GTase rates of each PBP1B version. Data are the rate of glycan polymerisation relative to WT PBP1B (mean ± SD, n = 3–4). The presence 
or absence of LpoB is indicated beneath appropriate bars with a + or −, respectively. Statistical significance was tested by paired T-Test (as 
in panel a); N.S., not significantly different; *, P ≤ 0.05; **, P ≤ 0.005. 
C. Basal TPase and GTase activities of each PBP1B version correlation plot. The activity of each version was calculated relative to WT 
PBP1B activity as a percentage, relative GTase activity is plotted along the x-axis against relative TPase activity on the y-axis. WT PBP1B 
activity is displayed across the plot as coloured lines ± SD in corresponding lighter shade (TPase in Green, GTase in Blue). The dashed line 
represents the region on which data would fall if both activities have been altered to a similar magnitude. I202F activity is omitted from the 
plot as its inclusion skews the scale such that other points are illegible (basal GTase = 785% of WT, basal TPase = 128% of WT). 
D. Specific activation of each PBP1B version by LpoB. In this plot the fold GTase stimulation of each PBP1B version by LpoB is plotted on the 
x-axis against the total increase in TP products produced by that version in the presence of LpoB relative to the increase caused by LpoB on 
WT PBP1B. WT PBP1B activation is displayed as coloured lines ± SD in corresponding lighter shade (TPase in Green, GTase in Blue). The 
dashed line represents the region on which data would fall if activation of both activities has been impacted to a similar magnitude. 
E. Glycan chain length assays of PBP1B versions. PBP1B versions, indicated above the corresponding lanes, were incubated with 
fluorescent lipid II substrate at the same conditions as for the PG synthesis and GTase assays with ampicillin to block cross-linking. The 
presence of LpoB is indicated with a + above the appropriate lane, its absence with a -. After the reaction, resulting glycan chains were 
resolved by SDS-PAGE and visualised by fluorescence imaging. The position at which the substrate runs is marked by ‘Lipid II’, glycan chain 
length is given in disaccharide units. [Colour figure can be viewed at wileyonlinelibrary.com]
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residues enhanced the effect LpoB binding has on the 
UB2H domain.
Substitutions affecting the GTase activity alone. D198A, 
a substitution we predicted to impact GTase activation, 
had no effect on basal TPase activity, or on its activation 
by LpoB (Fig. 3A). This substitution did however affect 
GTase activity, slightly increasing the basal rate (1.3-
fold) while impeding the activation by LpoB (Fig. 3B and 
D). Similarly, K437A, which is involved in a H-bonding 
network with aromatic residues in the inter-domain 
core of PBP1B and with the extremity of Loop 1, did not 
impact TPase activity (Fig. 3A and C) but affected GTase, 
inhibiting both basal activities (decreased to ~0.5-fold of 
WT) and total activity in the presence of LpoB (Fig. 3B).
Downstream effects of the H-bond connection between 
UB2H and the GTase domain. In seeking a rationale for 
why reorientation of the R157-E341 H-bond at the top 
of α-helix 7 in the GTase domain (Fig. 2A) may activate 
catalysis we substituted residues K355 and Q318 to Ala. 
K355 is at the opposite end of this α-helix 7 proximal to 
the essential catalytic residue E233. Q318 is connected 
indirectly to E341 through a H-bonding network and 
forms part of the glycan chain exit channel of the domain. 
Substitution of either of these residues had a strong 
negative impact on basal GTase activity, K355A having 
weakest activity of all versions tested at 0.18 ± 0.03-fold, 
and Q318A at 0.35 ± 0.06-fold (Fig. 3B and C). Binding of 
LpoB to K355A and Q318A had the strongest stimulatory 
effect of all versions tested, significantly greater than the 
usual 10-fold activation, at ~37- and 25-fold, respectively 
(Fig. 3B and D). Despite this magnitude, activation was not 
sufficient to return total WT PBP1B-LpoB levels of activity.
Unexpectedly, K355A also had a strong positive impact 
on basal TPase activity, increasing TPase products to 
58.4 ± 2.1%. Similar to versions N112G, R134E and 
I202F with increased basal TPase activity the binding of 
LpoB only enhanced activity to the typical WT PBP1B-
LpoB level and no further. It is difficult to reconcile how 
such a distal substitution can have such an effect on 
TPase activation. This will be discussed below. Q318A 
had normal basal TPase activity, but impaired activa-
tion by LpoB synthesising 63.7 ± 1.9% TPase products. 
A possible explanation for this effect is the observation 
that this version made significantly shorter glycan chains 
than WT PBP1B (Fig. 3E), perhaps too short to allow high 
levels of TPase activity as the peptide substrate may not 
reach the active site as efficiently and/or frequently. Using 
a SDS-PAGE based GTase assay, allowing visualisation 
of glycan chain length in the absence of TPase, in our 
conditions PBP1B produced glycan chains of ~20–25 
disaccharide units in length on average. Contrary to 
previous reports we observed that LpoB induced PBP1B 
to produce glycan chains with a broader length distribu-
tion (Fig. 3E). It was reported that LpoB had the oppo-
site effect, inducing PBP1B to produce shorter chains 
(Paradis-Bleau et al., 2010). However, these data were 
obtained in the presence of 20% of the organic solvent 
DMSO and we replicate this solvent artefact (Fig. 3E). 
Q318A produced glycan chains with an average length of 
~8 disaccharide units, and binding of LpoB had no effect 
on this length distribution (Fig. 3E). The defect in length 
is not caused by a general decrease in GTase activity as 
K355A, though much slower in rate than WT, shows the 
same length distribution as WT PBP1B with or without 
LpoB (Fig. 3E). This chain length defect, as well as the 
decrease in total TPase activity with LpoB, are likely the 
reasons the Q318A substitution cannot complement a 
loss of PBP1B in the cell (Fig. 2B).
Structural dynamics is important for PBP1B activation
Destabilisation of the terminal β-sheet of UB2H induced 
by LpoB binding may increase structural dynamics in 
residues connected to this region via H-bonding net-
works (Figs 1C and 2A) such as the Loop 1 residue 
R157, crucial for GTase activation signal transduction via 
H-bonding with E341. We predicted that the dynamics 
of this loop and/or the connection between R157 and 
E341 may be required for signal transduction. Thus, we 
sought to alter the dynamics in two ways. Firstly we trun-
cated Loop 1, removing residues 158–160 in an attempt 
to reduce overall flexibility. This version (PBP1BΔ158–160) 
was non-functional in the cell (Fig. 2B). Secondly we 
introduced disulphide bridges between Loop 1 and the 
inter-domain region of PBP1B with two double substitu-
tions; D160C/K437C and P162C/I644C (Fig. 4A). Each 
of these three versions was purified and bound Bocillin 
(Fig. S2B). We detected no free thiol groups in either of 
the disulphide versions, or the WT PBP1B, by quantita-
tion with DTNB reagent suggesting that the disulphide 
bridges are intact.
Truncation of Loop 1 strongly decreased basal PBP1B 
GTase activity to 0.27 ± 0.05-fold that of WT (Fig. S3) with-
out significantly impacting basal TPase activity (remaining 
similar to WT at 47.2 ± 1.0%). This truncation completely 
blocked the GTase activation signal from UB2H, with addi-
tion of LpoB having no effect on the polymerisation rate, 
which remained at 0.30 ± 0.07-fold that of WT (Figs 4 and 
S3). Blocking the GTase activation signal in this manner 
also impacts the stimulation of TPase by LpoB giving only 
53.8 ± 1.0% TPase products. Restricting motion of this 
loop by addition of a disulphide between its centre and the 
inter-domain region of PBP1B (D160C/K437C) strongly 
inhibited activation of both GTase and TPase activities by 
LpoB (Fig. 4). This inhibition was completely reversed by 
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addition of the disulphide reducing agent TCEP suggest-
ing the effect was caused by the disulphide and not the 
substitutions themselves. Restricting the loop at its periph-
ery, more distal to the R157-E341 connection (P162C/
I644C) also negatively impacted GTase activation but to 
a lesser degree. Again, this inhibition was reversed by 
reduction of the disulphide bond. Importantly, the addition 
of TCEP had no effect on WT PBP1B activity or stimula-
tion by LpoB (Figs 4 and S3). Similarly to the K355A sub-
stitution, introduction of the disulphide between residues 
162 and 644 had an unexpected positive effect on TPase 
activity. This will also be discussed below.
We hypothesised that disruption of the H-bonding 
between the TPase domain and UB2H through R109 
and D443 could increase TPase activity by allowing the 
whole domain more freedom of movement relative to the 
rest of the enzyme, consistent with a previously reported 
hypothesis based on the structure of some bifunctional 
PBPs (Lovering et al., 2008; 2012). We sought to test if 
this possible general increase in dynamics of the TPase 
domain was responsible by introducing disulphide bonds 
between the TP domain and UB2H through two double 
substitutions; R109C/D443C and L127C/V445C, the 
later residues not implicated in signal transduction, nor 
part of α-helix 14 (Fig. 4A). These disulphides would, 
in theory, prevent release of the TPase domain if such 
a change happens. As above, these versions were puri-
fied, bound Bocillin (Fig. S2B) and had no detectable 
free thiol groups indicating the disulphides are in-place. 
Introduction of a disulphide between residue 127 and 445 
had no impact on PBP1B activation by LpoB, suggesting 
that overall dynamics of the TPase domain as a whole 
was not responsible for the increased activity. However, 
the connection between residues 109 and 443 appears 
Fig. 4. Disturbing structural dynamics impacts PBP1B regulation. 
A. Representation of short distances measured between the UB2H domain and the rest of PBP1B (PDB code 5FGZ). The residues coloured 
in orange are those replaced by Cys in pairs to form disulphide bridges between the UB2H domain and the TP or GT domain. 
B. Total TPase activity of PBP1B disulphide and truncation versions. Data are the total products resulting from TPase domain activity during 
in vitro PG synthesis using native [14C]-lipid II substrate (mean ± SD, n = 3–4). The presence or absence of LpoB or TCEP is indicated 
beneath appropriate bars with a + or −, respectively. Statistical significance was tested by paired T-Test compared to the appropriate WT 
activity (as in Fig. 3); *, P = < 0.05; **, P = < 0.005; no indication, no significant difference. 
C. GTase rates of each PBP1B disulphide and truncation versions. Data are the rate of glycan polymerisation relative to WT PBP1B or to the 
specific version as indicated to the left of each graph (mean ± SD, n = 3–4). The presence or absence of LpoB or TCEP is indicated beneath 
appropriate bars with a + or −, respectively. [Colour figure can be viewed at wileyonlinelibrary.com]
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to be important for basal PBP1B activity. When the con-
nection was intact, the protein had normal TPase activity 
with increased basal GTase activity compared to WT by 
3.2 ± 0.2-fold (Fig. 4B and C). Upon reduction the GTase 
activity was decreased and basal TPase activity dropped 
to similar levels as those observed in R109G substitution 
versions (41.4 ± 2.0%) (Fig. 3A). Activation by LpoB was 
not significantly affected. This suggests that while the 
overall motion of the TPase domain relative to the rest 
of the protein is probably not a mechanism of stimulation 
by LpoB, the dynamics of α-helix 14 within this domain is 
involved in controlling activity. Considered together with 
the effect of R109G on basal PBP1B activities these data 
suggest that this residue and its connections are crucial 
for maintaining an active conformation of the enzyme.
Altering the active state of PBP1B affects LpoB binding
The affinity between some of the PBP1B versions and 
LpoB was measured by SPR (Table 2 and Fig. S4). LpoB 
bound to WT PBP1B with an apparent KD of ~0.5 μM and 
rapid on/off rate, consistent with our previous observa-
tions (Fig. S4) (Egan et al., 2014). The affinity between 
PBP1B I202F and LpoB was significantly higher, with an 
apparent KD value of 26 nM. Furthermore, the typically 
rapid on/off rate of the interaction between PBP1B and 
LpoB was altered in I202F, with a qualitatively decreased 
off-rate (Fig. S4B). These data show that LpoB inter-
acts more strongly with a more active PBP1B version. 
Consistent with this, other versions with increased basal 
activity, D443A and N112G, showed a minor but repro-
ducible increase in affinities with apparent KD values of 
~0.29 and 0.36 μM, respectively. PBP1B R109G, which 
had decreased basal activities, interacted with LpoB with 
a weaker affinity (KD of ~3 μM) suggesting that the con-
verse is also true. Taken together these data suggest that 
LpoB binding to PBP1B is affected by the active state of 
the synthase. Exceptions to this observation are R157A 
and E341A, which both have decreased basal activi-
ties but retain affinities with LpoB similar to WT, or even 
increased in the case of E341A. We offer possible expla-
nations in the discussion.
Mapping the CpoB interaction with PBP1B reveals the 
mechanism of inhibition
To understand why CpoB could have a negative effect on 
the stimulation of PBP1B TPase but not GTase activity 
by LpoB (Gray et al., 2015) we investigated the complex 
formation between CpoB and the UB2H domain. The 
X-ray crystal structure of the trimeric N-terminal domain 
of CpoB from E. coli was solved in 2010 (Krachler et al., 
2010) but not for the C-terminal domain. The C-terminal 
domain structure was instead solved using the homol-
ogous domain from Xanthomonas campestris, and 
revealed an organisation as a TetratricoPeptide Repeat 
domain (TPR) (Krachler et al., 2010). Previously, we pro-
posed that the C-terminal TPR domain of CpoB interacts 
with PBP1B in E. coli (Gray et al., 2015). Here we have 
determined the structure of the C-terminal TPR domain 
of CpoB from E. coli by NMR and found it adopts a fold 
similar to the X. campestris homologue (data deposited 
in BMRB and PDB, accession number 34256 and 6G5S, 
respectively). The domain is comprised of a series of 
seven helices that strongly and sequentially interact to 
form a TPR domain (Fig. S5). The structures of E. coli 
and X. campestris CpoBTPR only differ in the N-terminal 
helix orientation.
We validated our previous model of the CpoBTPR (res-
idues 139–263) interaction with PBP1B by SPR. Purified 
CpoBTPR bound to PBP1B immobilised to a chip surface 
with an apparent KD of 4.9 ± 1.9 μM (Table 2, Fig. S4). 
This was a significant decrease in affinity compared to 
full length CpoB, which interacted with an apparent KD 
of 94 ± 30 nM. To explain this difference we assessed 
whether the N-terminal ‘coiled-coil’ domain is involved in 
Table 2. Apparent dissociation constants of different PBP1B versions with LpoB and three CpoB constructs as determined by SPR.
PBP1B version
Apparent dissociation constant, KD ± SD μM
LpoB LpoB (reducing) CpoB CpoBTPR CpoBCC
WT 0.491 ± 0.037 0.094 ± 0.030 4.9 ± 1.9 N.B.
R109G 3.09 ± 0.09 0.070 ± 0.003
D443A 0.289 ± 0.017 0.095 ± 0.001
N112G 0.356 ± 0.024 0.089 ± 0.002
E341A 0.273 ± 0.024 0.077 ± 0.002
R157A 0.505 ± 0.073 0.357 ± 0.040 0.147 ± 0.024
I202F 0.026 ± 0.001 0.017 ± 0.001 > 2.0
Δ158-160 1.90 ± 0.29 1.70 ± 0.19 N.B.
D160C/K437C 3.97 ± 0.51 2.04 ± 0.61
P162C/I644C 0.213 ± 0.001 0.182 ± 0.035
N.B., no binding detected. Reducing – dissociation measured in reducing conditions (2 mM TCEP in SPR running buffer).
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the interaction, but found it to be dispensable. We then 
checked whether the inter-domain linker region was 
involved, purifying a CpoBTPR version with this linker (res. 
110–263) but the affinity remained similar (Fig. S4). A per-
haps key difference between CpoB and CpoBTPR is that 
the later does not trimerise as effectively, with the majority 
existing in a monomeric state (Krachler et al., 2010).
To map the interaction surfaces between UB2H and 
CpoB, we have used Paramagnetic Relaxation Enhanced 
(PRE) NMR-based detection (Clore and Iwahara, 2009; 
Hartl et al., 2012). In this approach, one binding partner is 
randomly spin labelled on lysine residues while the other 
partner is 15N isotopically enriched. Here we measured 
intensity ratios for [15N]-CpoB and [15N]-UB2H in the 
presence of the reciprocal spin labelled partner (Fig. 5A). 
Residues with an intensity ratio below 0.75 are coloured 
in orange on surface representations of the two proteins 
revealing regions of proximity (Fig. 5B). For CpoB, the 
proximity mainly localised in the α-helix H4 (residues 
198, 200, 201, 204, 205, 207), residues 208, 209, 212, 
α-helix H5 (residues 220, 221, 223), and α-helix H6 
(residues 238, 239, 242, 243). For UB2H the affected 
residues were located in the N- and C-terminal β-sheet 
extremities (strands β1′ and β7′), which we have identified 
as playing a role in TPase activation by LpoB earlier in 
this work. Residues located in the Loop 1 (R157, D160, 
K165 and E166) were also affected. Additional proximi-
ties were observed in the loop formed by two anti-parallel 
β-sheets (residues 156–165 region). The PRE-NMR data 
measured on UB2H and CpoB were used to calculate an 
updated model of the CpoBTPR-PBP1B-LpoB complex 
using the data-driven HADDOCK molecular docking soft-
ware by the same protocol as for our previously published 
model (Gray et al., 2015) (Fig. 5C).
Next we assessed whether CpoBTPR modulates the 
activation of PBP1B by LpoB by counteracting the struc-
tural changes it induces in UB2H. We tested the effect of 
CpoBTPR on the TPase activity of PBP1B versions which 
showed increased basal activity: D443A, N112G, K355A, 
I202F. The presence of CpoBTPR decreased the peptides in 
cross-links synthesised by PBP1B-LpoB from 68.9 ± 2.0% 
to 60.5 ± 0.9%, a decrease in the proportion of stimula-
tion of 43% (Fig. 5D). CpoBTPR inhibited the increase in 
basal TPase activity of D443A by 43.4 ± 12.6%, a similar 
proportion to WT, suggesting this residue is involved in 
the dampening effect. D443A interacts with CpoB with the 
same affinity as WT PBP1B (apparent KD of 95 ± 1 nM) 
(Table 2). Conversely, N112G, K355A, and I202F are all 
immune to the effect of CpoBTPR, with its presence hav-
ing no effect on their respective increases in basal TPase. 
Like D443A, N112G interacts with CpoB with a similar 
apparent KD to WT of 89 ± 2 nM, however I202F showed 
only weak binding to CpoB at the concentrations used. 
Given that CpoBTPR has a 50-fold lower KD than the full 
protein this particular observed immunity may be due to 
lack of sufficient binding instead of direct effect on the 
stimulatory structural changes.
We additionally tested the effect of CpoBTPR on the 
above versions with LpoB, and on those versions which 
were stimulated by LpoB to a higher degree, R109G/
N112G, R109G/R196G, R109G/N112G/R196G. In all 
cases the substitutions rendered PBP1B immune to the 
inhibitory effect in the presence of LpoB. R109G interacts 
with CpoB with a similar KD value of 70 ± 3 nM suggesting 
that this effect is not due to perturbed interaction in the 
multiple substitution versions. While the basal increase 
in D443A TPase was sensitive to CpoBTPR modulation, 
the presence of LpoB overcomes this. This suggests 
CpoBTPR is able to stabilise the effect D443A has on α-he-
lix 14 in isolation, but not in the presence of the additional 
allosteric changes induced by LpoB.
Discussion
Despite the essentiality of class A PBPs in bacterial cell 
wall growth, their validation as effective antibiotic targets, 
and the identification of several protein interaction part-
ners which exert regulatory effects, mechanistic insight 
into how these enzymes are controlled has remained 
unknown. In this work, to our knowledge we present 
the first molecular details towards understanding how 
two regulatory proteins LpoB and CpoB exert control on 
their cognate PG synthase PBP1B in E. coli. Our work 
is centred on the characterisation of stimulatory confor-
mational changes induced in the regulatory domain of 
PBP1B, UB2H, by LpoB binding and how concurrent 
CpoB interaction with this domain selectively modulates 
these changes.
We found that binding of LpoB to UB2H caused struc-
tural changes, with a destabilisation of the anti-parallel 
β-sheet (strands β1′ and β7′) that connects the N- and 
C-termini of the UB2H domain and an increase in dynam-
ics of Loop 1 (Fig. 1). In this and our previous work on the 
UB2H-LpoB interaction interface we observed that resi-
dues located upstream of the C-terminus of UB2H, in an 
outward-facing loop, are important for the interaction with 
LpoB (N188, R190, Q191) (Egan et al., 2014). We postu-
late that the interaction between those residues and LpoB 
can stretch the C-terminal segment of UB2H and could 
be the reason for the drastic modification of the terminal 
β-sheet in the isolated UB2H. In the full PBP1B structure, 
this destabilisation effect could cause local reorientation 
of UB2H relative to the two catalytic domains. Such a 
reorientation would have an effect on the H-bond network 
that is formed between UB2H and the rest of the mole-
cule. Based on this structural evidence, we have inves-
tigated a possible allosteric mechanism that could use 
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Fig. 5. CpoB binds proximal to the TPase activation pathway in PBP1B. 
A. Paramagnetic Relaxation Enhancement (PRE) measured on NMR spectra of 15N-CpoB and 15N-UB2H after addition of Lys-spin labelled 
UB2H and CpoB proteins, respectively. The quantification of PRE was obtained by measuring the intensity before and after reduction of 
the nitroxide group covalently linked to the epsilon amino group of the Lysine. Ratio that show a significant variation (< 0.75) are coloured in 
orange. Red stars represent resonances that completely disappear after addition of the paramagnetic protein. 
B. Residues with a PRE ratio < 0.75 are coloured in orange on the structure of CpoB (left) and UB2H (right). 
C. Data-driven docking integrating PRE experimental data and previous cross-linking data (Gray et al., 2015) was calculated from the 
structure of PBP1B (PDB 5FGZ) and the C-terminus E coli CpoB domain lowest energy structure (PDB 6G5S). The lowest energy structure 
obtained with HADDOCK/CNS protocols is displayed with UB2H and CpoB domains coloured in pale blue and blue, respectively. 
D. Peptides in cross-links produced by PBP1B versions in the presence of LpoB, CpoB, or both (mean ± SD, n = 3–4). Presence or absence 
of each regulator protein in reaction assays is indicted beneath each bar with a + or −, respectively. Statistical significance was tested by 
paired T-Test compared to the appropriate activity (indicated by connecting line); *, P ≤ 0.05; **, P ≤ 0.005; no indication, no significant 
difference. [Colour figure can be viewed at wileyonlinelibrary.com]
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the stability of the H-bond network connecting the UB2H 
domain to the rest of PBP1B.
PBP1B cycles between active and inactive 
conformations through structural dynamics
Our findings suggest that destabilisation of the terminal 
β-sheet of UB2H constitutes part of the activation signal 
through two effects. A direct impact of this destabilisation 
is on α-helix 14. One end of this helix is proximal to the 
TPase active-site cleft, the other end interacts with res-
idue R109 in the destabilised region of UB2H via D443. 
Upon destabilisation, α-helix 14 is likely either slightly 
reoriented, more dynamic, or both, and this structural 
change improves catalysis. A secondary effect of the 
destabilisation of the terminal β-sheet is on the dynamics 
of UB2H’s contact to the GTase domain via the R157-E341 
H-bond proximal to Loop 1. Residue E341 in the GTase 
domain is directly connected to the cap of α-helix 7. K355 
at the opposite end of α-helix 7 is proximal to the essen-
tial E233 catalytic residue in the GTase active cleft. King 
et al. noted that this proximity may be important in main-
taining the crucial negatively charged form of E233 by 
electrostatic stabilisation (King et al., 2016). Indeed we 
found a critical role of K355 in GTase activity and found 
the version in which K355 is substituted for Ala to be 
extremely receptive to activation by LpoB (Fig. 3). Based 
on our data we postulate that the LpoB induced destabil-
isation of the UB2H β-sheet increases dynamics of Loop 
1, in-turn increasing dynamic motion of α-helix 7 which is 
favourable for catalysis. Together with the effect on α-he-
lix 14 this constitutes the allosteric activation pathways 
(Fig. 6A). Precisely how these changes boost the respec-
tive functions is unknown as NMR with the full length 
PBP1B-LpoB complex is not feasible because of the 
molecular weight of >110 kDa and obtaining a co-crys-
tal of PBP1B in complex with LpoB is problematic, likely 
due to the highly dynamic nature of the interaction. The 
activation signal proposed here is consistent with pre-
viously identified versions of PBP1B, isolated through 
suppressor selection, which are able to partially bypass 
the need for activation by LpoB (Markovski et al., 2016). 
Two of these, I202F and Q411R, cluster in the inter-do-
main region of PBP1B proximal to both α-helix 14 and 
Loop 1. A third, Q447K, is part of α-helix 14 (Fig. 2A). We 
currently have no insight into how a fourth suppressor 
versions isolated by Markovski et al., E313D, is exerting 
its bypass effect.
Our observation that the destabilisation effect driven by 
LpoB binding affects UB2H’s connection to the TPase and 
GTase domain explains how LpoB binding simultaneously 
stimulates both activities. It also offers one explanation for 
why many of the substitutions we made aiming to impact 
one or the other activation pathways in fact impacted 
both as they share the same root, the UB2H terminal 
β-sheet. One residue however, had an opposite effect to 
our prediction and other residues nearby in the pathway. 
R109G caused basal TPase and GTase activity of PBP1B 
Fig. 6. Regulation of PBP1B function. 
A. LpoB binding to UB2H activates PBP1B through two conformational rearrangement pathways. Binding destabilises the β-sheet featuring 
N112 and R196 proximal to R109 at the base of TPase domain α-helix 14 capped by D443. This change may reorient and/or increase 
motional dynamic of α-helix 14, in turn impacting structure within the active site cleft promoting catalysis. LpoB binding also increased 
dynamic movement of UB2H Loop 1, from which R157 makes a H-bond with the GTase domain via E341. Increased movement of this loop 
may reorient and/or increase movement of α-helix 7 in the GTase domain, which connects to the active site cleft through K355, and to the 
glycan chain exit channel though Q318. This reorientation likely impacts the local structure around these residues, improving catalysis. 
Binding of CpoB, which may be the default state in the cell, is proximal to the TPase activation pathway and specifically dampens this 
activation signal by affecting the motion of α-helix 14. This dampening is relieved in response to Tol-Pal function (Gray et al., 2015). 
B. Cartoon representation of the two means of activation of PBP1B. PBP1B can exist in two states, inactive (off) or active (on). The synthase 
can be activated in two ways: (1) direct binding of LpoB induces the conformational changes shifting PBP1B to the active state (‘activation’), 
(2) the necessary conformational changes sporadically occur in PBP1B causing activation, and LpoB binding affinity is increased favouring 
binding and stabilisation of this active state (‘stabilisation’). Without LpoB to stabilise this state the frequency with which this sporadic 
activation occurs and/or the length of time PBP1B is active are not sufficient for effective PG synthesis in the cell. [Colour figure can be 
viewed at wileyonlinelibrary.com]
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to decrease significantly. Furthermore, this substitution 
caused a decrease in the PBP1B-LpoB affinity of ~6-fold 
(Table 2). A simple explanation would be that its overall 
folding was disrupted, however it both bound Bocillin and 
interacted with CpoB with the same affinity as WT, sug-
gesting that the protein is folded. Given that the strongly 
active I202F substitution increased LpoB binding affinity, 
and reduced the off-rate of the binding, we concluded that 
while I202F exists predominantly in an active conforma-
tion R109G exists in an inactive one. These observations 
along with our data showing that structural dynamics are 
important for PBP1B activation led us to postulate that 
PBP1B is able to sporadically self-activate through the 
same changes induced by LpoB binding, and that the 
R109G substitution causes the synthase to revert to the 
inactive state more rapidly by abnormal dynamics. The 
positive effect of a disulphide bridge between R109 and 
D443 supports this hypothesis (Fig. 4B). When intact, the 
active conformation is stabilised leading to the increase in 
basal GTase activity we observed, which is reversed once 
the connection is severed causing the synthase to be 
prone to reverting to the inactive state more rapidly similar 
to R109G. The ability to sporadically self-activate would 
explain why the synthase is active in isolation in vitro. 
While the majority of the molecules are in an inactive or 
off state, a minority exist in the active state able to perform 
catalysis. This notion is consistent with previous obser-
vations (Markovski et al., 2016). The activity observed 
would be proportional to the longevity of this active state. 
It is likely that some of the other substitutions we made 
in probing the activation pathways also impacted the lon-
gevity of the active state explaining their effect on both 
activities, such as D443A and R134E, or had unexpected 
effect on one, such as the effect of K355A and the P162C/
I644C disulphide on TPase activity.
How does CpoB impair TPase activation?
By mapping the positions on UB2H to which CpoBTPR
 
interaction is proximal we find an explanation for its 
selective modulation of activation (Fig. 5). According to 
PRE NMR CpoBTPR binding is on or near the upper por-
tion of UB2H proximal to the TPase domain, including 
part of the destabilised β-sheet, putting it in proximity to 
the TPase activation pathway through α-helix 14. The 
increase in TPase activity caused by D443A substitu-
tion was dampened by CpoBTPR to the same degree 
as WT PBP1B-LpoB is, suggesting the inhibitory effect 
works to counter the conformational shift of α-helix 14. 
Consistent with this, versions with multiple substitutions 
in this pathway that enhance β-sheet destabilisation 
(R109G, N112G, R196G) are immune to the dampen-
ing effect of CpoBTPR. Together these interaction and 
activity data suggest that in the WT situation, binding 
of CpoBTPR dampens the TPase activation pathway 
through stabilisation of the terminal β-sheet region of 
UB2H (Fig. 6A). Whether the stabilisation is complete or 
not is unknown. If it were only partial it may explain why 
inhibition of the activation signal is not total. CpoB exists 
in 10× greater amounts than PBP1B in the cell (500 vs. 
5000 copies) suggesting that the CpoB-bound state is 
the default. Its inhibitory effect on PBP1B activation by 
LpoB is only relieved through the functioning of the Tol-
Pal system (Fig. 6A) (Gray et al., 2015). Of note is that 
PBP1B with a truncation of Loop 1 (Δ158–160) showed 
no binding to CpoB with the protein concentrations 
tested (Table 2, Fig. S4). This result is in agreement 
with the chemical shift perturbations observed by NMR 
on UB2H (Fig. 5A) and with the proximity observed in 
the calculated model between the Loop 1 and CpoBTPR 
(Fig. 5C). If indeed CpoB does also interact proximal 
to, or directly with, this loop its binding has no effect on 
the GTase activation signal in E. coli PBP1B, as we’ve 
previously reported (Gray et al., 2015). Perhaps E. coli 
CpoB is an exception, evolving to lose this ability, and 
versions from other species may exert a more total inhi-
bition of their cognate class A PBP.
Cellular context of PBP1B regulation
Taken together, our in vivo and in vitro data reveal a 
minimal level of PBP1B function required for growth 
(in the absence of the functionally redundant PBP1A). 
We observed that cells relying on PBP1B function 
need the synthase to have a GTase rate at least 8 to 
9-fold greater than our measured WT basal rate and 
the ability to produce at least 66% TPase products in 
the presence of LpoB. Any version, which has less 
activity than this, cannot support cell growth in the 
absence of PBP1A. This observed minimal require-
ment may explain why Markovski et al. (2016) could 
not delete both LpoB and PBP1A when cells were reli-
ant on PBP1B I202F for growth, as the activity of this 
version in the absence of LpoB is below the observed 
threshold, with GTase activity 7.8 ± 1.2-fold above 
WT and TPase activity at 64 ± 1.3%. So even though 
this version is much more active alone, it still requires 
LpoB for full activity.
While sporadic activation suffices for observation of 
PBP1B activity alone in vitro, this is insufficient in the 
absence of LpoB in the cell, as the minimal threshold 
is not reached. Thus, we propose that LpoB ensures 
PBP1B is functional in the cell in two ways: (1) binding 
of LpoB induces the required conformational changes 
directly, consistent with an induced fit model (Koshland, 
1958; Zhang and Al-Hashimi, 2009), as we’ve observed 
this effect on UB2H by NMR spectroscopy; (2) given that 
LpoB interacts stronger with more active conformations 
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of PBP1B, when/if the synthase sporadically activates, 
LpoB binding is favoured which stabilises the active 
conformation, consistent with a tertiary capture model 
(Foote and Milstein, 1994; Zhang and Al-Hashimi, 2009) 
(Fig. 6B). Without LpoB to induce and/or stabilise this 
state the frequency with which this sporadic activation 
occurs and/or the length of time PBP1B is active are 
not sufficient for the minimal PG synthesis threshold 
in the cell. This model is consistent with a previous 
report showing that limited PBP1B activity in the cell 
in the absence of LpoB is responsible for cell death 
(Markovski et al., 2016; Greene et al., 2018). R157A 
and E341A appear to be exceptions to this hypothesis 
as they have lower basal activities similar to R109G but 
retain similar affinity to LpoB as WT. Given that TPase 
activity requires ongoing GTase activity, such that 
catalysis is coupled, we postulate that the lower basal 
activity of these versions is not due to the substitutions 
affecting the longevity of the active state. Rather, it is 
because it blocks the GTase activation pathway. Even if 
the synthase sporadically self-activates with the same 
frequency as WT, the activation signal cannot efficiently 
progress to the GTase domain to increase catalysis, in 
turn impacting the efficiency of the TPase.
There are numerous examples of class A PBPs across 
the bacterial kingdom, including representatives from 
both Gram-positive and Gram-negative phyla, which pos-
sess small non-catalytic sequences or domains revealed 
either bioinformatically or when the protein’s structure 
was solved (Han et al., 2011; Typas et al., 2012; Jeong 
et al., 2013). In this work we have demonstrated how 
induced conformational changes in one such domain, E. 
coli PBP1B’s UB2H, control the activity of the synthase. 
While this work has focussed on the molecular details 
of this specific example, we expect that similar regula-
tory relationships exist wherever non-catalytic domains/
sequences are found, and that the specific activators sim-
ply remain to be discovered.
Experimental procedures
Chemicals and proteins
[13C]-glucose was purchased from Cambridge Isotope Labs. 
The [15N]-NH4Cl, and all other chemicals used, were pur-
chased from Sigma-Aldrich unless otherwise stated. Lipid II 
versions were prepared as previously described (Breukink 
et al., 2003; Bertsche et al., 2005). The following proteins 
and antibodies were prepared as previously described: 
LpoB (Egan et al., 2014), UB2H (Egan et al., 2014), CpoB 
(Gray et al., 2015), and anti-PBP1B (Bertsche et al., 2006). 
CpoBTPR and CpoBCC versions were prepared by the same 
procedure as for CpoB. Cellosyl was provided by Hoechst 
AG, Frankfurt (Germany). Bacillus cereus β-lactamase (569/
H9) was purchased from Merck.
Bacterial strains
Bacterial strains and plasmids used in this work are listed in 
Tables S2 and S3, respectively. Primers used in this work 
are listed in Table S4.
Growth conditions
For growth assays, cells were grown aerobically at 30°C or 
37°C in Lennox Luria-Bertani (LB) medium (10 g/L tryptone, 
5 g/L yeast extract, 5 g/L NaCl) or Miller LB (10 g/L tryptone, 
5 g/L yeast extract, 10 g/L NaCl), or on solid versions of these 
supplemented with 1.5% (w/v) agar as indicated. Where 
appropriate, additional supplements were added: chloram-
phenicol (20 μg/mL), kanamycin (30 or 50 μg/mL), cefsulodin 
(6 μg/mL), sodium citrate (10 mM). For protein production, 
cells were grown aerobically at 30°C or 37°C in 1.5 L (unless 
otherwise stated) of Miller LB medium with 50 μg/mL kana-
mycin. Protein production was induced by addition of 1 mM 
IPTG once cells had reached OD578 0.5–0.6 unless other-
wise stated. Induction proceeded for at least 3 h at 30°C. For 
production of isotopically labelled proteins, kanamycin-re-
sistant BL21 (DE3) cells containing the plasmid of interest 
were grown in M9 minimal media with [15N]-NH4Cl (1 g/L) for 
singly labelled or both [15N]-NH4Cl (1 g/L) and [13C]-glucose 
(2 g/L) for doubly labelled protein overexpression, as appro-
priate. First a 10 mL pre-culture in Lennox LB was grown for 
few hours at 37°C to OD600 1.0. This culture was back-di-
luted (10-fold dilution) in a second 100 mL pre-culture in M9 
containing appropriate isotopically labelled compound(s) 
and grown overnight at 37°C. 2 L of the M9 medium sup-
plemented with vitamins (1 g/L pyridoxine, 1 g/L biotin; 
1 g/L D-pantothenic acid hemicalcium salt, 1 g/L folic 
acid, 1 g/L choline chloride, 1 g/L niacinamide, 0.1 g/L 
riboflavin, and 5 g/L thiamine) and salts (1 mM MgSO4, 
0.1 mM CaCl2, 0.1 mM MnCl2, 50 M ZnSO4, and 0.1 mM 
FeCl3) was inoculated to OD600 0.2 and incubated at 37°C 
until the culture reached OD600 1.0 at which point 1 mM IPTG 
was added to induce protein expression for 3 h at 30°C.
Construction of plasmids
Expression vectors for oligo-histidine tagged recombinant 
PBP1B108–200 (UB2H), CpoB139–263 (CpoBTPR), CpoB110–263 
(CpoBTPR+link), and CpoB27–109 (CpoBCC) with a thrombin 
cleavage site were created by insertion of the gene into 
pET28a at Nde I and Hind III restriction sites. Expression 
vectors for oligo-histidine tagged PBP1B versions were cre-
ated by mutagenesis of pDML924 encoding PBP1B46–844 
(Terrak et al., 1999). Mutagenesis was performed using a 
QuikChange lightning kit (Agilent technologies, USA) as per 
the manufacturer’s instructions.
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Construction of E. coli strains
To generate an antibiotic selection marker-less mrcB dele-
tion (ΔmrcB::FRT) the kan-marked allele from the E. coli sin-
gle gene knockout KEIO (Datsenko and Wanner, 2000; Baba 
et al., 2006) collection strain was transformed with plasmid 
pCP20 encoding a FLP recombinase, which excises the kan 
cassette by virtue of FRT sites flanking the kan allele leaving 
an FRT-site scar in place (Cherepanov and Wackernagel, 
1995). ΔmrcB::FRT was transformed with plasmids carrying 
PBP1B versions, including the WT and empty pET28a vec-
tor, to be used to assess growth fitness, and survival in the 
absence of both mrcA and mrcB. Expression of each PBP1B 
version was assessed by western blot detection of the pro-
tein from whole-cell lysate of exponentially growing cells in 
Lennox LB at 30°C (Fig. S2A).
Growth fitness assays
To generate E. coli strains in which growth is dependent on 
the specific plasmid-borne PBP1B version P1 transduction 
was used to transfer ΔmrcA::cat into BW25113 ΔmrcB::FRT 
transformed with the pertinent plasmid (Thomason et 
al., 2007). Strains were grown overnight in 5 mL Lennox 
LB at 30°C. Cultures were pelleted, resuspended in 2 mL 
of 10 mM MgSO4, 5 mM CaCl2, pelleted again and finally 
resuspended in another 2 mL of 10 mM MgSO4, 5 mM 
CaCl2. 100 μL of cells were incubated at 30°C with 2 μL of 
P1 phage derived from BW38029 ΔmrcA::cat, after which 
1 mL of Lennox LB with 30 μg/mL kanamycin and 10 mM 
sodium citrate was added. Cells were incubated at 30°C for 
1 h with shaking before plating on Lennox LB with 30 μg/mL 
kanamycin, 20 μg/mL chloramphenicol and 10 mM sodium 
citrate. Plates were incubated at 30°C until visible colony 
growth. Colonies were screened by PCR to check for the 
absence of both mrcA and mrcB from the chromosome.
For quantitation of growth fitness of strains expressing 
each PBP1B version relative to cells expressing WT, PBP1B 
ΔmrcB::FRT transformed with the pertinent plasmids were 
replica pinned on Lennox LB agar with 6 μg/mL cefsulodin 
in two independent arrays. Each strain was pinned in qua-
druplicate in each array. Plates were incubated at 37°C for 
12 h and imaged. Colony size was quantified using the image 
analysis software Iris (Kritikos et al., 2017).
Protein purification
E. coli BL21(DE3) transformed with the appropriate plas-
mid was used for all protein production in this work. 
As indicated above UB2H, LpoB, CpoB (and its sub-
domains) were purified as previously described (Egan 
et al., 2014; Gray et al., 2015). In brief cells harvested 
by centrifugation were resuspended in 25 mM Tris/HCl, 
500 mM NaCl, 20 mM imidazole buffer at pH 7.5, in the 
presence 10 mg lysozyme and RNase/DNase. Cells were 
disrupted by sonication and the cell debris were removed 
at 46,000×g for 45 min at 4°C. The supernatant was loaded 
on a 10 mL HisTrap chelating column (GE Healthcare, USA) 
and the protein was eluted using a 40 to 400 mM imidaz-
ole concentration gradient. The protein was further purified 
in 10 mM Tris/HCl, 200 mM NaCl buffer at pH 7.5 using a 
Superdex 200 size exclusion chromatography column (GE 
Healthcare, USA). The sample was concentrated for NMR 
experiments, for which the histidine-tag was conserved. 
The procedure for PBP1B purification was modified from 
Bertsche et al. (2006) to improve efficiency and ensure con-
sistency between preps. Protein production was performed 
as described above in ‘growth conditions’ at 30°C through-
out. Cells harvested by centrifugation were resuspended in 
80 mL of 25 mM Tris/HCl, 500 mM NaCl, 1 mM EGTA, 10% 
glycerol, pH 7.5 to which 1 in 1000 protease inhibitor cock-
tail (Sigma-Aldridge) and 100 μM phenylmethanesulfonyl 
fluoride (PMSF) was added. The resuspension was frozen 
at 80°C until required (< 3 months), at which time it was 
rapidly thawed and cells disrupted by sonication. The mem-
brane fraction was pelleted by centrifugation at 130,000 × 
g for 1 h at 4°C and resuspended in 25 mM Tris/HCl, 5 mM 
MgCl2, 1 M NaCl, 20% glycerol, 2% Triton X-100, pH 7.5 
with protease inhibitor cocktail and PMSF added as before. 
Extracted membranes were again centrifuged at 130,000 × 
g for 1 h at 4°C to remove remaining insoluble debris before 
1:1 dilution with 25 mM Tris/HCl, 5 mM MgCl2, 1 M NaCl, 
40 mM imidazole, 20% glycerol, pH 7.5 and application to 
an equilibrated 5 mL HisTrap column attached to an ÄKTA 
Prime+ system (GE Healthcare, USA) with fraction collec-
tion. Once the sample had been fully applied the column 
was washed with 40 mL of 25 mM Tris/HCl, 5 mM MgCl2, 
1 M NaCl, 40 mM imidazole, 20% glycerol, 0.2% Triton 
X-100, pH 7.5. Bound His6-PBP1B was eluted stepwise with 
25 mM Tris/HCl, 5 mM MgCl2, 1 M NaCl, 400 mM imidaz-
ole, 20% glycerol, 0.2% Triton X-100, pH 7.5. His6-PBP1B 
containing fractions were pooled in regenerated cellulose 
dialysis membrane with a molecular weight cut-off of 6–8 
kDa (Spectrum Labs, USA) and treated with 50 U/mL 
thrombin (Novagen, Merck, USA) for 20 h at 4°C during 
dialysis against 25 mM Tris/HCl, 5 mM MgCl2, 1 M NaCl, 
20% glycerol, pH 7.5. Protein was then dialysed in prepara-
tion for ion exchange chromatography, first against 20 mM 
NaOAc, 1 M NaCl, 10% glycerol, pH 5.0; then against the 
same buffer with 300 mM NaCl; and finally against the 
same with 100 mM NaCl immediately prior to application 
to an equilibrated 1 mL HiTrap SP HP column attached to 
an ÄKTA Prime+ system (GE Healthcare, USA) with fraction 
collection. The column was equilibrated in 20 mM NaOAc, 
100 mM NaCl, 10% glycerol, 0.02% NaN3, 0.2% Reduced 
Triton X-100, pH 5.0 (buffer A). Once the sample had been 
applied the column was washed with 5 mL buffer A before 
elution of bound protein by gradient. The gradient was from 
0 to 100% buffer B (as A, with 2 M NaCl) over 14 mL. PBP1B 
elution peaks at ~75% B. To ensure consistency between 
all PBP1B version preparations, particularly that the deter-
gent concentration remained constant, 2 L of ion exchange 
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buffers A and B were prepared and used for all prepara-
tions. PBP1B containing fractions were pooled and dialysed 
in 3 mL volume dialysis cassettes (D-Tube maxi, molecu-
lar weight cut-off 6–8 kDa, Merck, USA) against 20 mM 
NaOAc, 500 mM NaCl, 20% glycerol, pH 5.0. As Triton 
X-100 micelles do not pass through the dialysis membrane 
the final buffer conditions are 20 mM NaOAc, 500 mM 
NaCl, 20% glycerol, 0.2% Reduced Triton X-100, pH 5.0.
Paramagnetic spin labelling of proteins
We use OXYL-1-NHS (1-oxyl-2,2,5,5-tetramethylpyrol-
line-3-carboxylate-N-hydroxysuccimide ester; Toronto 
Research Chemicals Inc.) in order to randomly paramagnet-
ically label the є-amino groups of lysines in CpoB or UB2H 
as previously described with modifications (Lawrence et al., 
1980; Hartl et al., 2012). A 178 mM stock solution of OXYL-
1-NHS was prepared in DMSO and stored under argon at 
20°C. Protein was labelled in a buffer of 10 mM Na2CO3, pH 
9.2 at 20 μM. OXYL-1-NHS was added at 120 μM and the 
mixture was incubated at room temperature for 1 h and at 
4°C for an additional 4 h. Finally, the excess of OXYL-1-NHS 
was removed from the reaction mixture by using a 10 kDa 
cut-off concentrator and washing the sample with at least 
20 volumes of 10 mM Tris/HCl, 200 mM NaCl, buffer at pH 
7.5 and the protein concentration was adjusted to 100 μM in 
this buffer.
NMR spectroscopy
For structure determination, NMR spectra were recorded 
at 20°C on a 0.5 mM [13C,15N]-UB2H sample in 10 mM Tris/
HCl, 200 mM NaCl buffer at pH 7.5 containing 10% D2O, 
or a 2 mM [13C,15N]-UB2H sample with 1.2 molar ratio of 
unlabelled LpoB in the same buffer, or a 2 mM [13C,15N]-
CpoBTPR sample in the same buffer. For each sample 
assignment of 1H, 13C and 15N backbone and side-chain 
resonances was performed using a set of 3D heteronuclear 
experiments including BEST-TROSY-HNCACB, BEST-
TROSY-HN(CO)CACB, HNCO, HN(CA)CO, hCCH-TOCSY 
and HcCH-TOCSY. These datasets were collected on 
Bruker Avance spectrometers operating at 700 or 800 MHz 
1H-frequency equipped with triple-resonance cryogenic 
probes. 3D 15N-NOESY-HSQC, 3D aliphatic and aromatic 
13C-NOESY-HSQC experiments were acquired with mix-
ing times of 150 ms on a Bruker Avance US2 spectrometer 
equipped with a triple-resonance cryogenic probe to obtain 
structural restraints (see below). Data were processed 
using Bruker software and analysed in CcpNmr (Vranken 
et al., 2005).
Extraction of structural restraints and structure 
calculation
Distance restraints from 3D 15N-NOESY-HSQC, as well as 
from 3D aliphatic and aromatic 13C-NOESY-HSQC exper-
iments, were obtained after automatic peak picking and 
assignment performed by UNIO’10 version 2.0.2 (Guerry 
and Herrmann, 2012). TALOS+ was used to calculate the 
chemical shift index (using HN, N, Cα, Cβ and CO chemical 
shifts extracted from CcpNmr), to calculate the S2 parame-
ters of the backbone amide and to determine dihedral angle 
restraints from chemical shifts (Shen et al., 2009). The 
structures of UB2H alone, UB2H in complex with LpoB, and 
CpoBTPR were calculated with Aria 2.3.1 using 100 struc-
tures for each of the 8 iterations, with the exception of the 
last cycle where 750 structures were calculated (Rieping et 
al., 2007). The 20 lowest energy structures from the last iter-
ation underwent explicit water refinement in the NMR mod-
ule of the Crystallography and NMR System (Brünger et 
al., 1998). Structures were visualised with Pymol Molecular 
Graphics System, Version 1.5.0.4 (Schrödinger, LLC) for 
data analysis and figure preparation.
In vitro protein interaction and activity assays
The interactions among UB2H, LpoB and CpoB were eval-
uated by NMR in solution at 850 MHz, by following the 
intensity changes of the cross peaks on the 2D HN-HSQC 
spectra recorded at 20°C. All protein interaction assays were 
performed by using at least one 15N-labelled protein sam-
ple, with the other protein partners non-labelled or randomly 
spin labelled on the є-amino groups of lysine residues. The 
molar ratio of labelled versus unlabelled protein was 1:2 and 
a 100 M concentration in the mixture was used for the 
15N-labelled protein. The paramagnetic effect on 15N-UB2H 
and 15N-CpoB was reduced by addition of sodium ascor-
bate at a concentration of 1.2 and 1.6 mM, respectively. The 
quantification of PRE (paramagnetic relaxation enhance-
ment) for each resonance was carried out by the ratio of 
signal intensity in the oxidised and reduced states, before 
and after addition of sodium ascorbate, respectively:
The interaction affinities of LpoB and CpoB versions of 
PBP1B were measured by Surface Plasmon Resonance 
assays as described previously with minor changes (Egan 
et al., 2014; Gray et al., 2015). The concentration of LpoB 
injected ranged from 19.5 nM to 10 μM. The concentration 
of CpoB versions injected ranged from either 3.9 nM to 2 μM 
or from 78 nM to 40 μM. To assay binding in reducing condi-
tions 2 mM TCEP was included in the SPR running buffer, 
and PBP1B versions immobilised to the chip surface were 
incubated in this buffer for 30 min before the initiation of 
binding assays. The dissociation constant (KD) was calcu-
lated by non-linear regression using SigmaPlot 11.5 software 
IPRE= Iox/ Ired
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(Systat software Inc., USA) for at least three independent 
experiments.
Bocillin binding of the purified PBP1B versions was 
assessed by incubating 1 μg of each version in 20 μL of 
20 mM HEPES/NaOH pH 7.5, 5 mM MgCl2, 150 mM NaCl, 
0.05% Triton X-100 with or without 1 mM ampicillin at 37°C 
for 30 min. After which 50 ng of BOCILLINTM FL (Bocillin; 
Invitrogen, USA) was added before further incubation at 
37°C for 30 min. 15 μL of each sample was resolved by SDS-
PAGE, the gel then imaged by Typhoon scanner 9400 with 
excitation and emission filters of 488 and 520 nm, respec-
tively. The same gel was then stained using Coomassie 
Brilliant-Blue.
All activity assays were performed with 0.5 μM PBP1B (or 
versions there-of) with 2 μM LpoB, 50 μM CpoBTPR or both as 
indicated. Continuous fluorescence GTase assays were per-
formed as described previously, in a buffer of 50 mM HEPES/
NaOH pH 7.5, 25 mM MgCl2, 150 mM NaCl, 0.05% Triton 
X-100 at 30°C (Egan and Vollmer, 2016). Measurement of 
TPase activity using radiolabelled lipid II substrate was per-
formed as described by Bertsche et al. in a buffer of 20 mM 
HEPES/NaOH pH 7.5, 5 mM MgCl2, 150 mM NaCl, 0.05% 
Triton X-100 at 37°C (Bertsche et al., 2005). In activity assays 
(either of the above) performed at reducing conditions, 
10 mM TCEP (pH adjusted to 7.5 with NaOH) was added and 
proteins were incubated for 20 min at RT before proceeding. 
Measurement of glycan polymer lengths was performed 
largely as described previously with modifications to reaction 
conditions and the labelling of lipid II (Barrett et al., 2007; 
van’t Veer et al., 2016). Reactions were performed in a buffer 
of 20 mM HEPES/NaOH pH 7.5, 5 mM MgCl2, 150 mM NaCl, 
1 mM ampicillin, 0.05% Triton X-100 at 37°C. 20% DMSO 
was included where indicated. Substrate was prepared as 
follows: 5 μM ATTO550-labelled lipid II (analogous to Dansyl-
lipid II used for the continuous GTase assay) was mixed with 
25 μM lipid II in a solvent of 1:1 chloroform methanol. The 
mixture was dried, lipid II was then dissolved in 0.1% Triton 
X-100. Reactions were initiated by addition of the remain-
ing components to the substrate solution to a final volume 
of 50 μL. After 1 h incubation at 37°C 15 μL was removed 
and concentrated to 1 μL or dryness in a Scanvac vacuum 
concentrator (Labogene, Denmark), for reactions containing 
DMSO the centrifuge was set to 37°C to accelerate concen-
tration. Once dried, the resulting material was dissolved in 
4 μL sample buffer and resolved on Tris-Tricene SDS-PAGE 
gel. Once resolved the gel was imaged by Typhoon scanner 
9400, with excitation and emission filters at 532 and 580 nm, 
respectively.
Quantitation of free thiol groups in protein
Duplicate samples of 2 μM PBP1B version or L-Cys stan-
dards from 2 to 128 μM in 50 mM HEPES/NaOH, 5 mM 
MgCl2, 150 mM NaCl and 0.05% Reduced Triton X-100, pH 
7.5 were incubated in a 96-well plate at RT for 5 min prior 
to addition of 6 M GdnHCl (100 μL final sample volume) to 
denature protein. Samples were further incubated for 10 
min at RT prior to addition of 100 μL DTNB reaction solution 
(0.4 mM DTNB, 0.1 M Na2HPO4, 1 mM EDTA, 6 M GdnHCl, 
pH 8.0). The reaction was incubated for 15 min at RT before 
measurement of absorbance at 405 nm in a Tecan Infinite 
F50 microplate reader (Tecan, Switzerland).
Data-driven structural docking models
The docking models of CpoB/PBP1B were built using 
HADDOCK2.1 data-driven docking protocols (Dominguez 
et al., 2003) and CNS1.2 (Brünger et al., 1998) for the struc-
ture calculations. The model was calculated with the same 
protocol as described previously (Gray et al., 2015) but using 
the E. coli C-terminal domain of CpoB determined by NMR 
(PDB 6G5S). In addition to the previous restraints defined by 
in vivo cross-linking between CpoB and PBP1B, quantifica-
tion of PRE was used to define supplementary intermolec-
ular restraints. Residues with a PRE ratio of 0.75 (Fig. 5A) 
were added as active restraints (i.e. residues 109, 114, 119, 
120, 131,132, 157, 160, 165, 184, 194, 195 and 197 for UB2H 
and residues 198, 200, 201, 204, 205, 207, 208, 209, 212, 
220, 221, 223, 238, 239, 242 and 243 for CpoBTPR).
Accession numbers
Coordinates of 20 structures and chemical shifts of UB2H 
with/without LpoB have been deposited in the Protein Data 
Bank and the BioMagResBank under the accession codes 
6G5R/6FZK and 34255/34246, respectively. Coordinates 
of 20 structures and chemical shifts of CpoBTPR have been 
deposited in the Protein Data Bank and the BioMagResBank 
under the accession codes 6G5S and 34256, respectively.
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